LUMO
Lumos Pharma Inc
Halal Rating :
Last Price
$4.35
Last updated:
Market Cap
-
7D Change
0.23%
1 Year Change
42.62%
Company Overview
Industries
Exchange
Next Earnings Date
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for rare diseases. Their lead product candidate is LUM-201, an oral growth hormone secretagogue targeting pediatric growth hormone deficiency (PGHD) and other rare endocrine disorders.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $726000.0 | $8.37m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $488000.0 | $8.31m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $165000.0 | $11.03m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Lumos Pharma Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.